Infant Malaria Vaccine Schedule Optimization | MicrobiomeTrials← Back to trialsNCT06879327
Infant Malaria Vaccine Schedule Optimization
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-05-30Est. Completion: 2027-09-27
Enrollment target: 964 participants Locations- Institut de Recherche en Sciences de la Santé (IRSS), Bobo-Dioulasso, Burkina Faso
- Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
Other microbiome trials you might be interested in
Malaria
Background:
Malaria is a disease caused by parasites transmitted to people by mosquitoes. Around the world, there were …
Bethesda, United StatesEst. completion Nov 26, 2027
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Recruiting
Background:
Malaria is a serious infection caused by a parasite. People get malaria when an infected mosquito bites the…
Bethesda, United StatesEst. completion Sep 30, 2030